Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Página 1 desde 68 resultados
Method of identifying a candidate compound which may inhibit .alpha.9-nAchR overexpression or estrogen receptor-dependent transcription in nicotine-derived-compound-induced breast cancer cells
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The invention relates to methods of identifying a candidate compound which may inhibit estrogen receptor-dependent transcription or .alpha.9-nAChR overexpression and proliferation of nicotine-derived-compound-induced breast cancer cells. Particularly, an activating protein 1
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, AIDs, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
Methods for assessing cancer susceptibility to carcinogens in tobacco products
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally oncology and cancer susceptibility. More particularly, it concerns methods for assessing cancer susceptibility, particularly lung cancer susceptibility, to carcinogens in tobacco smoke and products.
2.
Genetic risk assessment technology for epithelial cancer involving gene-environment interaction between ERCC5 and tobacco use
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD
The present invention relates to methods and compositions useful for cancer diagnosis, prognosis, treatment and prevention.
BACKGROUND
Cancer causes a significant burden of disease around the world. In the United States, one of every three adults are expected to develop some form of cancer in
Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
This invention provides pharmaceutical compositions and compounds useful in methods of inhibiting cytochrome P450 2A6 and/or 2A13, reducing the use of tobacco products, reducing the exposure to nicotine and the harmful by-products associated with the use of tobacco products,
Small interfering RNAs and methods for prevention, inhibition and/or treatment of malignant progression of breast cancer
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The invention relates to small interfering RNAs (siRNAs) for inhibiting expression of .alpha.9-nAChR so as to inhibit breast cancer, methods to prevent/inhibit/treat malignant progression of nicotine-derived-compound-induced breast cancer (breast cancer induced by nicotine
Use of inhaled retinoids in the prevention of cancer
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
Retinoids are a class of naturally occurring and synthetic derivatives of Vitamin A which function in vivo as regulators of a number of physiological functions including cellular proliferation, cytodifferentiation and embryonal morphogenesis. This class includes a number
Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND
In other studies which we have made, we have considered the effects of glucosinolates. Glucosinolates are naturally-occurring constituents of cruciferous vegetables (Tookey, H. L., VanEtten, C. H. and Daxenbichler, M. E. (1980) Glucosinolates. In liener, I. E. (ed.), Toxic Constituents of
Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND
In other studies which we have made, we have considered the effects of glucosinolates. Glucosinolates are naturally-occurring constituents of cruciferous vegetables (Tookey, H. L., VanEtten, C. H. and Daxenbichler, M. E. (1980) Glucosinolates. In Liener, I. E. (ed.), Toxic Constituents of
Chewing gum composition for effectively eliminating nicotine accumulated in a human body
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention relates to a chewing gum composition for eliminating nicotine, and more particularly to such a composition capable of eliminating the nicotine component from the body of a person chewing the chewing gum.
DESCRIPTION OF THE PRIOR ART
Nicotine is known as a
Interferon and interferon inducers combined with tobacco products
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
Several patents attempt to medicate cigarettes generally (U.S. Pat. No. 977,635 by A. B. Klein; U.S. Pat. No. 1,974,242 by J. L. Jordan, Jr. et al.; U.S. Pat. No. 2,418,296 by S. S. Frederickson; U.S. Pat. No. 4,021,364 by P. Speiser et al.) with vitamins (U.S. Pat. No. 2,198,188 by A. Viscardi;
La base de datos de hierbas medicinales más completa respaldada por la ciencia
- Funciona en 55 idiomas
- Curas a base de hierbas respaldadas por la ciencia
- Reconocimiento de hierbas por imagen
- Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
- Leer publicaciones científicas relacionadas con su búsqueda
- Buscar hierbas medicinales por sus efectos.
- Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.
Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.
